These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26770729)

  • 1. Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up.
    Yagi N; Okada K; Sudo Y; Itoh H; Yoshida H; Kuroda T
    SAGE Open Med; 2014; 2():2050312114533960. PubMed ID: 26770729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results.
    Takeuchi T; Okada K; Yoshida H; Yagi N
    Mod Rheumatol; 2018 Jan; 28(1):85-94. PubMed ID: 28722500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
    Kagawa H; Hiromasa T; Yamanaka R; Hayashi R; Tsunashima Y; Inoue T; Sada KE
    Clin Exp Nephrol; 2018 Dec; 22(6):1371-1378. PubMed ID: 29948442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
    Nishi E; Kameda H; Ogawa H; Nagasawa H; Takei H; Okuyama A; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Sakai R; Ito T; Takeuchi T; Amano K
    Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H; Watanabe S; Aizawa-Yashiro T; Oki E; Kumagai N; Tsuruga K; Ito E
    Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
    Kuroda T; Hirose S; Tanabe N; Sato H; Nakatsue T; Ajiro J; Wada Y; Murakami S; Hasegawa H; Ito S; Sakatsume M; Nakano M; Gejyo F
    Mod Rheumatol; 2007; 17(3):206-12. PubMed ID: 17564775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H; Oki E; Tsuruga K; Sato N; Matsukura H; Matsunaga A; Kondo Y; Suzuki J
    Nephron Clin Pract; 2008; 110(2):c73-9. PubMed ID: 18758186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H; Tsugawa K; Nakahata T; Kudo M; Suzuki K; Ito E
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
    Zhang M; Xing CY; Liu J
    Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H; Hiromasa T; Hara T; Takaki A; Yamanaka R; Sada KE; Makino H
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
    Yoshidome K; Takei S; Imanaka H; Maeno N; Ohkawa T; Kawano Y
    Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
    Fu LW; Yang LY; Chen WP; Lin CY
    Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Ito E; Waga S
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H; Tsugawa K; Oki E; Suzuki K; Ito E
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST).
    Takeuchi T; Wakasugi N; Uno S; Makino H
    J Rheumatol; 2021 Jan; 48(1):74-81. PubMed ID: 32238515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.
    Fujinaga S; Endo S; Morishita T; Takemasa Y; Onuki Y; Sakuraya K; Hirano D
    Tohoku J Exp Med; 2022 Jan; 256(1):85-91. PubMed ID: 35095030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y; Fukuda W; Kawahito Y; Kohno M; Wada M; Ishino H; Hamaguchi M; Yamamoto A; Kadoya M; Niimi M; Yoshikawa T
    Mod Rheumatol; 2008; 18(1):91-5. PubMed ID: 18159569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.